Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapiesDenise M. Wolf, Laura van ‘t Veer, Christina Yau et al.|Cancer Cell|2022Cited by 335
An integrated tumor, immune and microbiome atlas of colon cancerJessica Roelands, Davide Bedognetti, Tatiana Carneiro-Lobo et al.|Nature Medicine|2023Cited by 205
Discriminating External and Internal Causes for Heading Changes in Freely Flying DrosophilaAndrea Censi, Michael H. Dickinson, Andrew Straw et al.|PLoS Computational Biology|2013Cited by 59
Abstract PD5-04: PD5-04 Characterizing the HER2-/Immune-/DNA repair (DRD-) response predictive breast cancer subtype: the hunt for new protein targets in a high-needs population with low response to all I-SPY2 agentsDenise M. Wolf, Laura van ‘t Veer, Christina Yau et al.|Cancer Research|2023Cited by 0
Abstract B077: Subtype-specific signaling dynamics during treatment in non-responding breast cancer patients in the neoadjuvant I-SPY2 TRIAL: are there clues on how to overcome resistance?Denise M. Wolf, Laura van ‘t Veer, Christina Yau et al.|Cancer Research|2024Cited by 0